170 related articles for article (PubMed ID: 16952352)
1. Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.
Zeng G; Apte U; Micsenyi A; Bell A; Monga SP
Exp Cell Res; 2006 Nov; 312(18):3620-30. PubMed ID: 16952352
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
[TBL] [Abstract][Full Text] [Related]
3. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP
Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939
[TBL] [Abstract][Full Text] [Related]
5. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
Matteucci E; Ridolfi E; Desiderio MA
Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
[TBL] [Abstract][Full Text] [Related]
7. Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation.
David MD; Yeramian A; Duñach M; Llovera M; Cantí C; de Herreros AG; Comella JX; Herreros J
J Cell Sci; 2008 Aug; 121(Pt 16):2718-30. PubMed ID: 18664491
[TBL] [Abstract][Full Text] [Related]
8. HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.
Davies G; Jiang WG; Mason MD
Int J Mol Med; 2001 Apr; 7(4):385-8. PubMed ID: 11254878
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
Soldati C; Biagioni S; Poiana G; Augusti-Tocco G
J Neurosci Res; 2008 Apr; 86(5):1044-52. PubMed ID: 17975841
[TBL] [Abstract][Full Text] [Related]
10. HGF/c-Met related activation of β-catenin in hepatoblastoma.
Purcell R; Childs M; Maibach R; Miles C; Turner C; Zimmermann A; Sullivan M
J Exp Clin Cancer Res; 2011 Oct; 30(1):96. PubMed ID: 21992464
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.
Xie Z; Eagleson KL; Wu HH; Levitt P
eNeuro; 2016; 3(4):. PubMed ID: 27595133
[TBL] [Abstract][Full Text] [Related]
12. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
Danilkovitch-Miagkova A; Miagkov A; Skeel A; Nakaigawa N; Zbar B; Leonard EJ
Mol Cell Biol; 2001 Sep; 21(17):5857-68. PubMed ID: 11486025
[TBL] [Abstract][Full Text] [Related]
14. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.
Herynk MH; Tsan R; Radinsky R; Gallick GE
Clin Exp Metastasis; 2003; 20(4):291-300. PubMed ID: 12856716
[TBL] [Abstract][Full Text] [Related]
15. beta-Catenin is critical for early postnatal liver growth.
Apte U; Zeng G; Thompson MD; Muller P; Micsenyi A; Cieply B; Kaestner KH; Monga SP
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1578-85. PubMed ID: 17332475
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
[TBL] [Abstract][Full Text] [Related]
17. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
19. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
Papkoff J; Aikawa M
Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
[TBL] [Abstract][Full Text] [Related]
20. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.
Li Y; Guessous F; Johnson EB; Eberhart CG; Li XN; Shu Q; Fan S; Lal B; Laterra J; Schiff D; Abounader R
Lab Invest; 2008 Feb; 88(2):98-111. PubMed ID: 18059365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]